With the traditional pharmacy leaders, Walgreen’s and CVS, expanding virtual and in-person care, while Amazon and Walmart leverage their footprints and subscription models—the frontline healthcare wars are about to get even more competitive.
OncoHost raises $35 million to further develop and test its precision oncology platform, combining proprietary bioinformatics, signal processing, and machine learning.
Medical experts recruited to advise Crisis Text Line say they weren’t consulted about its data sharing and voiced objection to the arrangement. “This would never have passed a sniff test,” one says.
H1 cofounders Ariel Katz and Ian Sax have scraped global healthcare data into a LinkedIn-like interface to help biopharma companies figure out the best doctor to involve in a clinical trial or educate about a new therapy.
Over the first four years of the Forbes Blockchain 50, the list of billion-dollar companies making meaningful use of the technology popularized by bitcoin, has become a bellwether of institutional adoption.
There have been massive increases in online searches for ivermectin, an antiparasitic repeatedly determined to be of no benefit in treating or preventing Covid-19, in areas with some of the lowest vaccination rates in the country.
It effectively creates a watchlist of newly-discovered viruses to help policymakers and health scientists prioritize them for further characterization, surveillance, and risk-reducing interventions.